TRAVERE THERAPEUTICS INC (TVTX) Institutional Ownership

TVTX is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $58.43M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $58.43M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's TVTX position is now estimated to be worth approximately $106.48M, representing an estimated gain of +82.23% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward TRAVERE THERAPEUTICS INC (TVTX).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$58,433,0041,966,779
Q4 20251$85,849,4262,246,779
Q3 20251$41,875,5251,752,114
Q2 20251$36,927,6872,495,114
Q1 20252$95,060,8695,304,736
Q4 20242$92,525,2685,311,439
Q3 20241$26,231,4461,875,014
Q2 20241$18,115,3512,203,814
Q1 20241$22,0662,862,014
Q4 20231$27,6983,081,014
Q3 20231$17,8271,994,122
Q2 20231$23,8851,555,013